Caruso Joseph A, Mathieu Patricia A, Joiakim Aby, Zhang Hong, Reiners John J
Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan 48201, USA.
J Biol Chem. 2006 Apr 21;281(16):10954-67. doi: 10.1074/jbc.M508383200. Epub 2006 Jan 30.
Recent studies suggest that the aryl hydrocarbon receptor (AhR) modulates susceptibilities to some pro-apoptotic agents. AhR-containing murine hepatoma 1c1c7 cultures underwent apoptosis following exposure to tumor necrosis factor-alpha (TNFalpha) + cycloheximide (CHX). In contrast, Tao cells, an AhR-deficient variant of the 1c1c7 line, were refractory to this treatment. AhR sense/antisense transfection studies demonstrated that AhR contents influenced susceptibility to the pro-apoptotic effects of TNFalpha + CHX. 1c1c7 cells and all variants expressed comparable amounts of TNF receptor-1 and TRADD. However, no cell line expressed FADD, and consequently pro-caspase-8 was not activated. AhR content did not influence JNK and NF-kappaB activation. However, Bid and pro-caspase-9, -3, and -12 processing occurred only in AhR-containing cells. Analyses of cathepsin B and D activities in digitonin-permeabilized cultures and the monitoring of cathepsin B/D co-localization with Lamp-1 indicated that TNFalpha + CHX disrupted late endosomes/lysosomes in only AhR-containing cells. Stabilization of acidic organelles with 3-O-methylsphingomyelin inhibited TNFalpha + CHX-induced apoptosis. The cathepsin D inhibitor pepstatin A suppressed in vitro cleavage of Bid by 1c1c7 lysosomal extracts. It also delayed the induction of apoptosis and partially prevented Bid cleavage and the activation of pro-caspases-3/7 in cultures treated with TNFalpha + CHX. Similar suppressive effects occurred in cultures transfected with murine Bid antisense oligonucleotides. These studies showed that in cells where pro-caspase-8 is not activated, TNFalpha + CHX can initiate apoptosis through lysosomal disruption. Released proteases such as cathepsin D trigger the apoptotic program by activating Bid. Furthermore, in the absence of exogenous ligand, the AhR modulates lysosomal disruption/permeability.
近期研究表明,芳烃受体(AhR)可调节对某些促凋亡剂的敏感性。含AhR的小鼠肝癌1c1c7细胞培养物在暴露于肿瘤坏死因子-α(TNFα)+放线菌酮(CHX)后发生凋亡。相比之下,Tao细胞是1c1c7细胞系的AhR缺陷变体,对这种处理具有抗性。AhR正义/反义转染研究表明,AhR含量影响对TNFα+CHX促凋亡作用的敏感性。1c1c7细胞及其所有变体表达相当数量的TNF受体-1和TRADD。然而,没有细胞系表达FADD,因此前半胱天冬酶-8未被激活。AhR含量不影响JNK和NF-κB的激活。然而,仅在含AhR的细胞中发生Bid以及前半胱天冬酶-9、-3和-12的加工。对洋地黄皂苷通透的培养物中组织蛋白酶B和D活性的分析以及对组织蛋白酶B/D与Lamp-1共定位的监测表明,TNFα+CHX仅在含AhR的细胞中破坏晚期内体/溶酶体。用3-O-甲基鞘磷脂稳定酸性细胞器可抑制TNFα+CHX诱导的凋亡。组织蛋白酶D抑制剂胃蛋白酶抑素A抑制1c1c7溶酶体提取物在体外对Bid的切割。它还延迟了凋亡的诱导,并部分阻止了在用TNFα+CHX处理的培养物中Bid的切割和前半胱天冬酶-3/7的激活。在用小鼠Bid反义寡核苷酸转染的培养物中也出现了类似的抑制作用。这些研究表明,在未激活前半胱天冬酶-8且含AhR的细胞中,TNFα+CHX可通过溶酶体破坏引发凋亡。释放的蛋白酶如组织蛋白酶D通过激活Bid触发凋亡程序。此外,在没有外源性配体的情况下,AhR调节溶酶体破坏/通透性。